ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
Avatar

Lecture Summary - ASCO 2022 Neoadjuvant HER2-Targeted Therapy +/- Immunotherapy With Pembrolizumab: An Open Label Randomized Phase 2 Trial

By ASCO 2022 Conference Coverage FEATURING Heather McArthur
By ASCO 2022 Conference Coverage FEATURING Heather McArthur
11 views
June 16, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh
Breast
54

Lecture Summary - ASCO 2022 Adjuvant Abemaciclib for High-risk Early…

ASCO 2022 Conference Coverage

S. Tolaney

52 views
07:17

ASCO 2022 Adjuvant Abemaciclib for High-Risk Early Breast Cancer: Fa…

ASCO 2022 Conference Coverage

S. Tolaney

397 views
01:10

Lecture Summary - ASCO 2022 A Phase 1b/2 Study of the BET Inhibitor …

ASCO 2022 Conference Coverage

P. Aftimos

21 views
10:53

ASCO 2022 A Phase 1b/2 Study of the BET Inhibitor ZEN-3694 in Combin…

ASCO 2022 Conference Coverage

P. Aftimos

37 views
10:23

ASCO 2022 Phase 2 Study of Lasofoxifene + Abemaciclib for Treating P…

ASCO 2022 Conference Coverage

S. Damodaran

271 views
10:12

ASCO 2022 on FLEX - the 30,000 Breast Cancer Transcriptome Project: …

ASCO 2022 Conference Coverage

C. Ma

153 views
01:04

Lecture Summary - ASCO 2022 Phase 2 Study of Lasofoxifene + Abemacic…

ASCO 2022 Conference Coverage

S. Damodaran

16 views
52

Lecture Summary - ASCO 2022 on FLEX - the 30,000 Breast Cancer Trans…

ASCO 2022 Conference Coverage

C. Ma

11 views
01:17

Lecture Summary - ASCO 2022 on Monitoring and Management of Intersti…

ASCO 2022 Conference Coverage

B. Feinberg

21 views
11:56

ASCO 2022 on Monitoring and Management of Interstitial Lung Disease/…

ASCO 2022 Conference Coverage

B. Feinberg

337 views
04:01

ASCO 2022 on Sacituzumab Govitecan vs. Treatment of Physician’s Choi…

ASCO 2022 Conference Coverage

A. Bardia

657 views
43

Lecture Summary - ASCO 2022 on Sacituzumab Govitecan vs. Treatment o…

ASCO 2022 Conference Coverage

A. Bardia

16 views
09:57

ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…

ASCO 2022 Conference Coverage

C. Dang

198 views
01:06

Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Acce…

ASCO 2022 Conference Coverage

C. Dang

40 views
06:19

ASCO 2022 Phase 2 Study of Response-Guided Neoadjuvant Sacituzumab G…

ASCO 2022 Conference Coverage

L. Spring

143 views
48

Lecture Summary - ASCO 2022 Phase 2 Study of Response-Guided Neoadju…

ASCO 2022 Conference Coverage

L. Spring

37 views
04:16

ASCO 2022 Analyses From PALOMA-2: Overall Survival With 1L Palbocicl…

ASCO 2022 Conference Coverage

D. Slamon

1.2K views
03:10

ASCO 2022 Neoadjuvant HER2-Targeted Therapy +/- Immunotherapy With P…

ASCO 2022 Conference Coverage

H. McArthur

89 views
04:36

ASCO 2022 A Single-Arm, Phase 2 Study of Perioperative Ipi, Nivo, an…

ASCO 2022 Conference Coverage

H. McArthur

21 views
56

Lecture Summary - ASCO 2022 Neoadjuvant HER2-Targeted Therapy +/- Im…

ASCO 2022 Conference Coverage

H. McArthur

11 views
37

Lecture Summary - ASCO 2022 A Single-Arm, Phase 2 Study of Periopera…

ASCO 2022 Conference Coverage

H. McArthur

9 views
50

Lecture Summary - ASCO 2022 on a Randomized Phase II/III PARTNER Tri…

ASCO 2022 Conference Coverage

R. Lucey

19 views
05:52

ASCO 2022 on a Randomized Phase II/III PARTNER Trial to Evaluate the…

ASCO 2022 Conference Coverage

R. Lucey

119 views
43

Lecture Summary - ASCO 2022 Overall Survival With 1L Palbociclib + L…

ASCO 2022 Conference Coverage

D. Slamon

24 views
03:41

ASCO 2022 Adherence to EndoPredict Test Scores for Extended ET Manag…

ASCO 2022 Conference Coverage

A. Brufsky

157 views
47

Lecture Summary - ASCO 2022 Adherence to EndoPredict Test Scores for…

ASCO 2022 Conference Coverage

A. Brufsky

12 views
01:03

Lecture Summary - ASCO 2022 on EFS by Residual Cancer Burden After N…

ASCO 2022 Conference Coverage

L. Pusztai

37 views
13:17

ASCO 2022 on EFS by Residual Cancer Burden After Neoadjuvant Pembro …

ASCO 2022 Conference Coverage

L. Pusztai

2.0K views
05:13

ASCO 2022 Optimization of the Duration of Adjuvant Endocrine Therapy…

ASCO 2022 Conference Coverage

B. Pistilli

39 views
34

Lecture Summary - ASCO 2022 Trastuzumab Deruxtecan vs. Trastuzumab E…

ASCO 2022 Conference Coverage

E. Hamilton

413 views
28

Lecture Summary - ASCO 2022 Optimization of the Duration of Adjuvant…

ASCO 2022 Conference Coverage

B. Pistilli

27 views
44

Lecture Summary - ASCO 2022 Impact of BMI on Treatment and Outcomes …

ASCO 2022 Conference Coverage

G. Pfeiler

16 views
43

Lecture Summary - ASCO 2022 on Alpelisib + Continued ET Following Pr…

ASCO 2022 Conference Coverage

C. Truica

65 views
04:56

ASCO 2022 Impact of BMI on Treatment and Outcomes in Patients With H…

ASCO 2022 Conference Coverage

G. Pfeiler

297 views
06:50

ASCO 2022 on Alpelisib + Continued ET Following Progression on ET in…

ASCO 2022 Conference Coverage

C. Truica

303 views
04:28

ASCO 2022 Subgroup Analysis of Patients With No Prior Chemo in Phase…

ASCO 2022 Conference Coverage

V. Kaklamani

286 views
30

Lecture Summary - ASCO 2022 Subgroup Analysis of Patients With No Pr…

ASCO 2022 Conference Coverage

V. Kaklamani

56 views
01:18

Lecture Summary - ASCO 2022 Survival Outcomes in Metastatic HR+, HER…

ASCO 2022 Conference Coverage

J. Mouabbi

17 views
09:18

ASCO 2022 Survival Outcomes in Metastatic HR+, HER2- IDC Compared to…

ASCO 2022 Conference Coverage

J. Mouabbi

802 views
31

Lecture Summary - ASCO 2022 on NRG-BR007: A Phase III Trial Evaluati…

ASCO 2022 Conference Coverage

J. White

22 views
10:55

ASCO 2022 on NRG-BR007: A Phase III Trial Evaluating De-Escalation o…

ASCO 2022 Conference Coverage

J. White

23 views
01:21

Lecture Summary - ASCO 2022 on the Type of ET and DFS in Early HER2+…

ASCO 2022 Conference Coverage

M. Vittoria Dieci

13 views
06:57

ASCO 2022 on the Type of ET and DFS in Early HER2+/HR+ BC: Analysis …

ASCO 2022 Conference Coverage

M. Vittoria Dieci

101 views
49

Lecture Summary - ASCO 2022: The ImPrint Immune Signature to Identif…

ASCO 2022 Conference Coverage

L. Mittempergher

37 views
11:09

ASCO 2022: The ImPrint Immune Signature to Identify Patients With Hi…

ASCO 2022 Conference Coverage

L. Mittempergher

263 views
32

Lecture Summary - ASCO 2022 on Estradiol Levels in Premenopausal Wom…

ASCO 2022 Conference Coverage

M. Tesch

40 views
10:19

ASCO 2022 on Estradiol Levels in Premenopausal Women With HR+ BC on …

ASCO 2022 Conference Coverage

M. Tesch

3.0K views
01:37

Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associa…

ASCO 2022 Conference Coverage

S. Shen

18 views
06:32

ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …

ASCO 2022 Conference Coverage

S. Shen

364 views
27

Lecture Summary - ASCO 2022 on Disparity Between Ki67 Measurements a…

ASCO 2022 Conference Coverage

R. Stein

11 views
08:04

ASCO 2022 on OPTIMA Preliminary Trial: Disparity Between Ki67 Measur…

ASCO 2022 Conference Coverage

R. Stein

1.4K views